Sep 02, 2026 8:30am EDT DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
Aug 10, 2026 4:30pm EDT DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Aug 04, 2026 4:30pm EDT DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
Jun 23, 2026 8:30am EDT DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
May 27, 2026 4:30pm EDT DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
May 20, 2026 8:30am EDT DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
May 12, 2026 4:15pm EDT DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 06, 2026 4:30pm EDT DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
